ClinicalTrials.gg

Program

VDPHL01

A development code. Also written as “VDPHL01 QD” and “VDPHL01 BID”.

Its studies are mostly in Alopecia, led by Veradermics.

Furthest: phase 3, since Dec 4, 20244 company-led studies, 4 open or runningNext primary completion: Dec 2026 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Veradermics44 open or runningphase 3since Dec 4, 2024Jul 25, 2024Dec 2026phase 3 · NCT06972264

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 25, 2024First study: phase 2 study in AlopeciaFirst studyNCT06527365 · 70 enrolled · United States
  2. Dec 4, 2024Phase 3 study in AlopeciaNCT06724614 · 480 enrolled · United States
  3. May 6, 2025Phase 3 study in AlopeciaNCT06972264 · 480 enrolled · United States
  4. Aug 12, 2025Phase 3 study in AlopeciaNCT07146022 · 552 enrolled · United States

Ahead

  1. Dec 2026Primary completion: phase 3 study in AlopeciaNCT06972264
  2. Jun 2027Primary completion: phase 3 study in AlopeciaNCT07146022

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07146022Alopecia · United States3Active, not recruitingJun 2027552
NCT06972264Alopecia · United States3Active, not recruitingDec 2026480
NCT06724614Alopecia · United States3Active, not recruitingFeb 2026480
NCT06527365Alopecia · United States2Active, not recruitingAug 202670

How it is read

Names in the registry

  • “VDPHL01”, 3 entries
  • “VDPHL01 QD”, 1 entry
  • “VDPHL01 BID”, 1 entry

Codes read as this program: VDPHL01.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.